Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin therapy that
has a high rate of morbidity (thrombosis and amputation) and mortality. In the past, a number …

Heparin‐induced thrombocytopenia (HIT) is a life‐threatening prothrombotic, immune‐
mediated complication of unfractionated heparin and low molecular weight heparin therapy …

Background: Heparin-induced thrombocytopenia presents 5 to 12 days after heparin
exposure, with or without arterial or venous thromboemboli. Delayed recognition and …

Clinical applications for recombinant hirudins have been investigated for the past 10 years.
The first indication for which a hirudin—lepirudin—has been approved is treatment of …

Background Heparin induced thrombocytopenia (HIT) is a potentially catastrophic syndrome
with a high incidence of vascular thrombosis. There are little data on the efficacy of new oral …

Heparin-induced thrombocytopenia (HIT) is an immune-mediated coagulation side effect of
heparin therapy characterized by thrombocytopenia and by a paradoxical prothrombotic …

As in adult patients, heparin is used for prophylaxis and treatment of thromboembolism in
newborns, children, and adolescents. Patients receiving heparin are potentially at risk to …

Heparin-induced thrombocytopenia (HIT), a well-known side effect of heparin therapy,
occurs with an incidence of 1–2% in certain pediatric patient groups. In affected children, HIT …

Thrombocytopenia is a frequent comorbid condition in many in hospital patients. In some
patients, drugs are the cause of low platelet counts. While cytotoxic effects of anti‐tumor …

OBJECTIVE: Emergent neurosurgery may be precipitated or complicated by previous or
concomitant administration of anticoagulants, thrombolytic medications, or antiplatelet …